Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/cod.14685 | DOI Listing |
Contact Dermatitis
January 2025
Guy's and St Thomas' NHS Foundation Trust, London, UK.
Front Psychiatry
September 2022
School of Medicine, Johns Hopkins University, Baltimore, MD, United States.
Anxiety associated with life-threatening illness (LTI) is a pervasive mental health issue with a wide impact. A spectrum of traditional pharmacotherapies and psychotherapies are available, but offer varying success in reducing symptoms and improving quality of life. We explore a novel therapy for this condition by assessing prominent thematic elements from participant narrative accounts of a pilot phase 2 clinical trial of 3,4 Methylenedioxymethamphetamine-Assisted Therapy (MDMA-AT) for treating anxiety associated with LTI.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!